Unbiased AI-powered news
A Medical University of Vienna study found inhaled PET microplastics remained detectable in mouse lungs for at least 14 days, triggered dose-dependent airway inflammation, and intensified responses to ragweed pollen. Researchers measured daily human inhalation estimates of 1–3 micrograms based on urban air concentrations.
The GuardianInhaled PET microplastic particles remained detectable in the lungs of mice for at least 14 days after a single administration, according to researchers at the Medical University of Vienna. The particles also induced dose-dependent airway inflammation accompanied by increased lymphocytes and eosinophils.
The study, published in the Journal of Hazardous Materials Advances, stated that PET microplastics remained detectable in the lung for 14 days and induced airway inflammation with lymphocyte and eosinophil recruitment.
When combined with ragweed pollen, the microplastics exacerbated inflammation and altered the body’s defensive response against the allergen. ” The researchers reported that PET microplastics are biologically active particles that alter airway inflammation and immune responses in a dose- and context-dependent manner.
They also concluded that PET microplastics persist in the lung, induce airway inflammation, and modulate immune responses in a dose, timing, and context-dependent manner.
Reported airborne levels of PET have reached about 135-158 nanograms per cubic metre of air in cities. Researchers calculated that an adult inhaling 10–20 cubic metres of air daily may take in about 1–3 micrograms of microplastics. The study noted that the results were obtained in mouse models and may not be directly extrapolated to humans.
Researchers added that the findings support the inclusion of immune endpoints while emphasising the need for cautious extrapolation to real-world exposure scenarios. Microplastic particles are under 5mm in size. PET is one of the most widely used plastics worldwide.
Single source — no framing comparison available.
New ScientistWestern Europe's first total solar eclipse since 1999 will occur on August 12 with totality visible in eastern Greenland, western Iceland and northern Spain. The peak of the Perseid meteor shower will follow hours later under new-moon conditions.
upi.comThe Food and Drug Administration approved enlicitide, sold as Lipfendra, on Thursday. Manufactured by Merck, the pill inhibits PCSK9 and cut LDL levels by up to 60 percent in a 24-week trial of 2,912 participants. It carries a list price of $315 for a 30-day supply and will reach…
flipboard.comEli Lilly will pay $2.8 billion in cash to acquire AtaiBeckley, a developer of psychedelic treatments for mental health conditions. The deal includes up to $1 billion in additional milestone payments. It adds the target’s compounds to Lilly’s neuroscience programs.